Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Completes $4.5 Billion Stock Buyback Ahead of Schedule

NEW YORK, June 22 (GenomeWeb News) - Agilent Technologies has completed its $4.5 billion stock repurchase program ahead of schedule, the company said today.


Agilent acquired approximately 125 million shares of its common stock under the program. Agilent expects to report approximately 430 million average shares outstanding on a fully diluted basis during its third quarter ending July 30.


Agilent's board of directors authorized the buyback program on Aug. 15, 2005, along with the sale of its semiconductor-related business. The buyback was projected to complete by the end of this year.


The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.